Please login to the form below

Not currently logged in
Email:
Password:

PureTech appoints Joseph Bolen as entrepreneur-in-residence

And Vincent Hennemand joins as VP, company development and operations

PureTech Health Joseph BolenBoston-based PureTech Health has appointed Joseph Bolen (pictured) as entrepreneur-in-residence.

He previously served as president of research and development at Moderna Therapeutics and as chief scientific officer at Millennium Pharmaceuticals.

Prior to joining Millennium in 1999, Dr. Bolen held senior R&D positions at Hoechst Marion Roussel, Schering-Plough, and Bristol-Myers Squibb.

As PureTech's entrepreneur-in-residence he will work with the firm's company creation team to identify and pursue promising new medicines.

Also joining PureTech, which focuses on developing novel medicines, is Vincent Hennemand.

He was formerly principal in Sanofi's corporate R&D venture group and joins the cross-disciplinary healthcare firm as its vice president of company development and operations.

Prior to that Hennemand was chief of staff to the president of global R&D and the general secretary for the corporate scientific advisory committee (SDSAC), which investigates scientific proposals and projects of potential interest to Sanofi.

9th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics